2026-01-15 - Analysis Report
**Company Overview**
UnitedHealth Group Inc is a diversified health care company.

### Financial Performance

#### Return Rate Comparison
* Review stock (UNH): -20.83%
* Comparison stock (VOO): 93.94%
* Divergence: -114.80

#### Alpha, Beta Analysis
| Year     | CAGR | MDD  | Alpha | Beta | Cap(B) |
|----------|------|------|-------|-------|---------|
| 2016-2018 | 22.0% | 18.6% | 19.0% | 0.9   | 227.9B  |
| 2017-2019 | 27.0% | 18.6% | 10.0% | 0.9   | 269.0B  |
| 2018-2020 | -41.0% | 32.5% | -62.0% | 1.1   | 320.9B  |
| 2019-2021 | 16.0% | 32.5% | -27.0% | 1.1   | 459.4B  |
| 2020-2022 | 0.0%  | 31.5% | 2.0%  | 0.9   | 485.1B  |
| 2021-2023 | 23.0% | 13.4% | 23.0% | 0.5   | 481.7B  |
| 2022-2024 | -24.0% | 23.1% | -44.0% | 0.4   | 462.8B  |
| 2023-2025 | -55.0% | 58.5% | -118.0% | 0.3   | 302.0B  |

### Stock Price Fluctuations

* Close: $333.93
* Last-market: $337.32
* Change: $1.02
* 5-day SMA: $341.39
* 20-day SMA: $334.87
* 60-day SMA: $335.16

### Technical Indicators Analysis

* Market Risk Indicator (MRI): 0.70
* RSI: 57.34
* PPO: 0.16
* Recent (20 days) relative divergence change: -2.70 (-): worsening
* 7-day Rank change: -54 (-): rank down
* 7-day Dynamic Expected Return change: -115.70 (-): worsening
* Expected Return (%): -351.80%
* If large fluctuation is observed, reflect the issue (sharp rebound, sharp decline).

### Analyst Opinions
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
- Opinions: 26
- Target Price (avg/high/low): 393.85 / 444.00 / 280.00

### Earnings Analysis

| Date    | EPS | Revenue |
|---------|-----|----------|
| 2025-10-28 | 2.59 | 113.16B$ |
| 2025-08-11 | 3.76 | 111.62B$ |
| 2025-05-07 | 6.9  | 109.58B$ |
| 2024-11-04 | 6.56 | 100.82B$ |
| 2025-10-28 | 6.56 | 100.82B$ |

* Earnings per share (EPS) has shown a fluctuating trend.
* Revenue has generally been increasing, with variations in quarterly results.

### Financial Information = 5. Financial Information

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

* Revenue has been steadily increasing over the past few quarters.
* Profit margin has shown a fluctuating trend.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

* Equity has shown a generally increasing trend.
* Return on Equity (ROE) has fluctuated over the past few quarters.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.